Loading clinical trials...
Loading clinical trials...
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Conditions
Interventions
Verum Cefaly® Abortive Program device
Sham Cefaly® Abortive Program device
Locations
10
United States
Clinical Research Consortium
Tempe, Arizona, United States
Pharmacology Research Institute
Encino, California, United States
Yale University
New Haven, Connecticut, United States
Palm Beach Research Center
West Palm Beach, Florida, United States
Meridian Clinical Research (Savannah Neurology)
Savannah, Georgia, United States
Meridian Clinical Research (Rockville Neurology)
Rockville, Maryland, United States
Start Date
April 10, 2018
Primary Completion Date
January 11, 2019
Completion Date
January 11, 2019
Last Updated
December 11, 2024
NCT06735833
NCT06810505
NCT06241313
NCT07071506
NCT07018713
NCT06641466
Lead Sponsor
Cefaly Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions